Testing the robustness of this finding on other BET inhibitors, two additional BET inhibitors (JQ1 and OTX015) were tested on four glioblastoma cell lines (Fig 4C) and showed consistent down-regulation of the FBXO5 module. This evidence concerns the gene FBXO5 and glioblastoma.